Last reviewed · How we verify
NCT03895190
Effects of a Application (Flourish App) in Medical Students
NA trial testing Flourishing App Program in Emotional Stress in 50 participants. Completed in 21 April 2020.
1 September 2019
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 50 |
| Start date | 6 August 2019 |
| Primary completion | 1 September 2019 |
| Estimated completion | 21 April 2020 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- Flourishing App Program
Conditions studied
- Emotional Stress — all drugs for Emotional Stress →
Sponsor
Hospital Israelita Albert Einstein
Who can join
17 and older, any sex, with Emotional Stress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This protocol proposes a well-being program, delivered through an application for mobile devices, based on meditation and positive psychology principles such as human development, the improvement of virtues, quality of life and well-being. The investigators hypothesize that this program offered in mobile application may promote well-being, reduce stress related problems and improving emotional regulation in the participants. Objectives: To evaluate the effectiveness of a well-being program delivered through an application for mobile devices in a sample of medical students. Methods: Three hundred students of the undergraduate medical course of Albert Einstein Israelite Faculty will be recruited. The participants will be randomized in two groups of 150 participants each one, half of them in the control group (GC) and the other half to the intervention group (GI).
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Mindfulness-based psychological interventions for improving mental well-being in medical students and junior doctors.
Sekhar P, Tee QX, Ashraf G, Trinh D, et al · · 2021 · cited 23× · PMID 34890044 · DOI 10.1002/14651858.cd013740.pub2
Verify or expand the search:
- PubMed search for NCT03895190
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Flourishing App Program
Trials testing the same drug.
- NCT03096171 — Flourishing App: An Evaluation With High School Students · NA · completed
Other recruiting trials for Emotional Stress
Currently open trials in the same condition.
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT06468111 — Dog-Assisted Therapy in Children During Blood or Dental Extraction. · NA · recruiting
- NCT04276363 — Families, Children and Teachers Thriving Together · NA · active not recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03895190 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 24 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03895190.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing